Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing [NA]
A clinical trial update noting ongoing recruitment for monitoring patients with HR-positive, HER2-negative metastatic breast cancer treated …
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT) [NA]
PRE-OPT is a clinical trial evaluating physical rehabilitation and optimal physical therapy for breast cancer patients. The study status is …
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer [Phase 2]
Phase II single-arm trial evaluating low-dose capecitabine in patients with metastatic breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer Treatment
This clinical trial update notes that the study examining WATD and cancer-related fatigue in patients undergoing anti-cancer treatment is cu…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
The document describes an ongoing clinical trial that collects peripheral blood or saliva samples for genetic epidemiology studies of famili…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluates combining anastrozole and palbociclib for metastatic HER2-negative breast cancer, with the study currentl…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer
This clinical trial update notes ongoing collection of tissue, blood, and cells at Memorial Sloan Kettering Cancer Center to study the cause…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Menstrual Cycle Maintenance and Quality of Life: A Prospective Study
Prospective clinical trial evaluating menstrual cycle maintenance and quality of life in individuals with amenorrhea within the breast cance…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Effect of Foot Reflexology On Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients [NA]
This clinical trial is evaluating whether foot reflexology can reduce chemotherapy-induced nausea and vomiting in breast cancer patients, wi…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Inspiratory Muscle Training in Obese Breast Cancer Survivors [NA]
This clinical trial is recruiting to evaluate inspiratory muscle training in obese breast cancer survivors. Sponsored by the Ohio State Univ…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Investigating Mechanisms to Explain Age Associated Differences in Quality of Life Among Breast Cancer Patients
A clinical trial update studying biological mechanisms underlying age-related differences in quality of life among breast cancer patients.
-
EMA approval · 2026-01-06EMA Authorised: Itovebi (inavolisib) — Roche Registration GmbH
EMA authorised Itovebi (inavolisib) by Roche Registration GmbH for breast cancer.
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant Therapy [Phase 2]
Phase 2 trial evaluating whether surgery can be omitted in clinically low-risk HER2-positive breast cancer patients who achieve complete res…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer [Phase 1, Phase 2]
Open-label Phase 1/2 umbrella trial evaluating elacestrant in various combination regimens for metastatic breast cancer is currently recruit…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: A Retrospective Analysis of Robot-Assisted Versus Endoscopic Breast-Conserving Surgery for Breast Cancer [NA]
This clinical trial update describes a retrospective analysis comparing robot-assisted versus endoscopic breast-conserving surgery for breas…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases [NA]
The fREEDOM trial for Resonance for Early Detection Of Breast Cancer Metastases is currently recruiting participants with invasive breast ca…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging [Phase 2]
Phase 2 clinical trial update on translating Acoustic Angiography with Contrast Enhanced Super Resolution (CESR) imaging, currently recruiti…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: A Study to Assess the Mass Balance of [14C]HRS-8080 in Healthy Chinese Postmenopausal Female Subjects. [Phase 1]
Phase 1 study to assess the mass balance of a radiolabeled compound [14C]HRS-8080 in healthy postmenopausal Chinese women; not yet recruitin…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Evaluation of a Cone-beam CT Scanner for Image Guided Radiotherapy [NA]
This clinical trial update reports the completed status and posted results for evaluating a cone-beam CT scanner used in image-guided radiot…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: A Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors [Phase 1]
This is an update on an ongoing Phase 1 clinical trial evaluating Lutetium-177Lu-BL-ARC001 in patients with lung cancer, breast cancer, and …
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: RWE About QOL and Compliance of Patients With OFS in China
A completed clinical trial provides real-world evidence on quality of life and adherence among patients treated with ovarian function suppre…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Pyrotinib Plus Neoadjuvant Chemotherapy in HR+/HER2-, HER4-High Breast Cancer [Phase 2]
A Phase 2 trial is assessing pyrotinib with neoadjuvant chemotherapy in hormone-receptor positive, HER2-negative, HER4-high breast cancer; t…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Toxicity Markers to Trastuzumab-Deruxtecan (T-DXd) In Patients With Advanced Breast Cancer
A clinical trial update describing planned analysis of toxicity markers for trastuzumab deruxtecan in patients with metastatic breast cancer…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Percutaneous Cryoablation of Low-risk Early Breast Cancer
A clinical trial update shows recruitment for low-risk early breast cancer using Percutaneous Cryoablation.
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer [Phase 2]
Phase 2 neoadjuvant trial evaluating chemotherapy with or without adebrelimab and trastuzumab deruxtecan for HR-positive, HER2-low early-sta…